Alphabet-owned company to begin human trials for cancer drug developed using AI
Pharmaceutical firm Isomorphic Labs is set to initiate human clinical trials for its oncology drugs created using AlphaFold 3, an AI tool developed by the company in collaboration with Google DeepMind. Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered […]
Continue Reading
